Annual CFF
$33.02 M
+$33.02 M+100.00%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual cash flow from financing activities is $33.02 million, with the most recent change of +$33.02 million (+100.00%) on December 31, 2023.
- During the last 3 years, ELDN annual CFF has fallen by -$76.56 million (-69.87%).
- ELDN annual CFF is now -69.87% below its all-time high of $109.58 million, reached on December 31, 2020.
Performance
ELDN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$5.28 M
-$42.79 M-89.01%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly cash flow from financing activities is $5.28 million, with the most recent change of -$42.79 million (-89.01%) on September 30, 2024.
- Over the past year, ELDN quarterly CFF has increased by +$5.28 million (+100.00%).
- ELDN quarterly CFF is now -94.45% below its all-time high of $95.23 million, reached on September 30, 2020.
Performance
ELDN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$53.35 M
+$5.28 M+10.99%
September 30, 2024
Summary
- As of February 7, 2025, ELDN TTM cash flow from financing activities is $53.35 million, with the most recent change of +$5.28 million (+10.99%) on September 30, 2024.
- Over the past year, ELDN TTM CFF has increased by +$20.34 million (+61.60%).
- ELDN TTM CFF is now -51.31% below its all-time high of $109.58 million, reached on December 31, 2020.
Performance
ELDN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ELDN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | +100.0% | +61.6% |
| 3 y3 years | -69.9% | +100.0% | +61.6% |
| 5 y5 years | +336.6% | +100.0% | +61.6% |
ELDN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7453.4% | -89.0% | -100.0% | at high | >+9999.0% |
| 5 y | 5-year | -69.9% | +7453.4% | -94.5% | +1274.0% | -51.3% | >+9999.0% |
| alltime | all time | -69.9% | +7453.4% | -94.5% | +1274.0% | -51.3% | >+9999.0% |
Eledon Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.28 M(-89.0%) | $53.35 M(+11.0%) |
| Jun 2024 | - | $48.07 M(>+9900.0%) | $48.07 M(+45.6%) |
| Mar 2024 | - | $1000.00(>+9900.0%) | $33.02 M(+0.0%) |
| Dec 2023 | $33.02 M(>+9900.0%) | $0.00(0.0%) | $33.02 M(0.0%) |
| Sep 2023 | - | $0.00(-100.0%) | $33.02 M(0.0%) |
| Jun 2023 | - | $33.02 M(>+9900.0%) | $33.02 M(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2022 | - | $0.00(0.0%) | $1000.00(-100.2%) |
| Dec 2021 | -$449.00 K(-100.4%) | $0.00(-100.0%) | -$449.00 K(-105.2%) |
| Sep 2021 | - | $1000.00(>+9900.0%) | $8.71 M(-91.6%) |
| Jun 2021 | - | $0.00(-100.0%) | $103.94 M(0.0%) |
| Mar 2021 | - | -$450.00 K(-104.9%) | $103.94 M(-5.1%) |
| Dec 2020 | $109.58 M(+1032.5%) | $9.16 M(-90.4%) | $109.58 M(+9.1%) |
| Sep 2020 | - | $95.23 M(>+9900.0%) | $100.42 M(+1834.4%) |
| Jun 2020 | - | $0.00(-100.0%) | $5.19 M(-64.8%) |
| Mar 2020 | - | $5.19 M(>+9900.0%) | $14.76 M(+52.5%) |
| Dec 2019 | $9.68 M(+28.0%) | $0.00(0.0%) | $9.68 M(-0.0%) |
| Sep 2019 | - | $0.00(-100.0%) | $9.68 M(-0.7%) |
| Jun 2019 | - | $9.57 M(+8843.0%) | $9.75 M(+5375.8%) |
| Mar 2019 | - | $107.00 K(>+9900.0%) | $178.00 K(-97.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $7.56 M(-3.9%) | $1000.00(-98.6%) | $7.56 M(-9.0%) |
| Sep 2018 | - | $70.00 K(>+9900.0%) | $8.31 M(+0.8%) |
| Jun 2018 | - | $0.00(-100.0%) | $8.24 M(-44.9%) |
| Mar 2018 | - | $7.49 M(+898.8%) | $14.96 M(+90.1%) |
| Dec 2017 | $7.87 M(+168.6%) | $750.00 K(>+9900.0%) | $7.87 M(+10.5%) |
| Sep 2017 | - | $0.00(-100.0%) | $7.12 M(-29.2%) |
| Jun 2017 | - | $6.72 M(+1579.8%) | $10.05 M(+205.2%) |
| Mar 2017 | - | $400.00 K(>+9900.0%) | $3.29 M(+12.4%) |
| Dec 2016 | $2.93 M(+471.2%) | $0.00(-100.0%) | $2.93 M(-1.6%) |
| Sep 2016 | - | $2.93 M(-8018.9%) | $2.98 M(+1161.9%) |
| Jun 2016 | - | -$37.00 K(-200.0%) | $236.00 K(-52.3%) |
| Mar 2016 | - | $37.00 K(-22.9%) | $495.00 K(-3.5%) |
| Dec 2015 | $513.00 K(-99.5%) | $48.00 K(-74.5%) | $513.00 K(-92.4%) |
| Sep 2015 | - | $188.00 K(-15.3%) | $6.72 M(-93.0%) |
| Jun 2015 | - | $222.00 K(+303.6%) | $95.46 M(+0.7%) |
| Mar 2015 | - | $55.00 K(-99.1%) | $94.81 M(+0.0%) |
| Dec 2014 | $94.80 M(+166.4%) | $6.25 M(-93.0%) | $94.80 M(+7.1%) |
| Sep 2014 | - | $88.94 M(<-9900.0%) | $88.55 M(<-9900.0%) |
| Jun 2014 | - | -$437.00 K(-991.8%) | -$388.00 K(-891.8%) |
| Mar 2014 | - | $49.00 K | $49.00 K |
| Dec 2013 | $35.59 M(+89.5%) | - | - |
| Dec 2012 | $18.78 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual CFF year-on-year change?
- What is Eledon Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly CFF year-on-year change?
- What is Eledon Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM CFF year-on-year change?
What is Eledon Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ELDN is $33.02 M
What is the all time high annual CFF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual cash flow from financing activities is $109.58 M
What is Eledon Pharmaceuticals annual CFF year-on-year change?
Over the past year, ELDN annual cash flow from financing activities has changed by +$33.02 M (+100.00%)
What is Eledon Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ELDN is $5.28 M
What is the all time high quarterly CFF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly cash flow from financing activities is $95.23 M
What is Eledon Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ELDN quarterly cash flow from financing activities has changed by +$5.28 M (+100.00%)
What is Eledon Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ELDN is $53.35 M
What is the all time high TTM CFF for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM cash flow from financing activities is $109.58 M
What is Eledon Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ELDN TTM cash flow from financing activities has changed by +$20.34 M (+61.60%)